Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplastic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02070406
What this trial is testing

Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT04903652
What this trial is testing

Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer

Who this might be right for
HER2-positive Advanced Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Ended earlyNCT02040558
What this trial is testing

Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Mallinckrodt 44
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Early research (Phase 1)Study completedNCT01898078
What this trial is testing

Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorsLymphoma
Millennium Pharmaceuticals, Inc. 26
Large-scale testing (Phase 3)Looking for participantsNCT07426055
What this trial is testing

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate BrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07551778
What this trial is testing

Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Colorectal CancerAdvanced Solid Tumors+2 more
BOE Technology Group Co., Ltd. 42
Testing effectiveness (Phase 2)UnknownNCT03890185
What this trial is testing

Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC

Who this might be right for
Nasopharyngeal Cancer
King Faisal Specialist Hospital & Research Center 108
Testing effectiveness (Phase 2)Ended earlyNCT01151215
What this trial is testing

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Who this might be right for
NeoplasmsBreast NeoplasmsBreast Cancer
AstraZeneca 482
Not applicableActive Not RecruitingNCT06504615
What this trial is testing

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

Who this might be right for
Gastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaEsophageal Adenocarcinoma (EAC)+1 more
Bristol-Myers Squibb 208
Testing effectiveness (Phase 2)UnknownNCT00006215
What this trial is testing

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Amgen
Testing effectiveness (Phase 2)Study completedNCT02855125
What this trial is testing

Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Who this might be right for
Advanced or Metastatic Non-small Cell Lung Cancer
Taiho Oncology, Inc. 128
Testing effectiveness (Phase 2)Study completedNCT00135135
What this trial is testing

Therapy for Children With Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 23
Testing effectiveness (Phase 2)UnknownNCT04524208
What this trial is testing

A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Carcinoma
Karsten Gavenis 45
Testing effectiveness (Phase 2)Looking for participantsNCT07486817
What this trial is testing

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

Who this might be right for
Lung Cancer, Non-squamous, Non-small Cell
Boehringer Ingelheim 60
Early research (Phase 1)UnknownNCT06127940
What this trial is testing

K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Karolinska University Hospital 20
Testing effectiveness (Phase 2)UnknownNCT02461849
What this trial is testing

Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy

Who this might be right for
Advanced, Refractory Cancer
Samsung Medical Center 14
Testing effectiveness (Phase 2)UnknownNCT04844385
What this trial is testing

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 124
Testing effectiveness (Phase 2)UnknownNCT01935843
What this trial is testing

Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors

Who this might be right for
Advanced HER-2 Positive Solid TumorsChemotherapy RefactoryHER-2 Antibody Inhibitor Therapy Refactory
Chinese PLA General Hospital 10
Not applicableUnknownNCT02726815
What this trial is testing

Developing a Symptom List for Children With Cancer

Who this might be right for
Paediatric Oncology Palliative Care
Royal Marsden NHS Foundation Trust 40
Next Page